This content is provided by Chambers. Learn more about our methodology
What the team is known for Highly regarded capital markets practice that harbors widely recognized expertise in the life sciences and technology sectors. Regularly engaged as issuer's counsel in high-value IPOs as well as an array of other securities offerings. Boasts a client base of top-tier investment banks, investors and companies, including an enviable stable of emerging businesses.
Strengths A client says: "For life sciences in particular they're very strong and they have a great client roster of biotech companies - that's tremendously helpful to understand the industry. It's a top-notch California firm."
Charlie Kim and Dave Peinsipp are both key contacts for this practice area.